I agree that this site is using cookies. You can find further informations here.
X
Mellenthin, Claudia
18  results:
OpenAccess-fulltext X
Search for persons X
?
1

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Dugic, Ana ; Verdejo Gil, Cristina ; Mellenthin, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312496/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Dugic, Ana ; Verdejo Gil, Cristina ; Mellenthin, Claudia...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/19802.  , 2022
Link: https://opus4.kobv.de/op..
 
?
3

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Mellenthin, Claudia ; Balaban, Vasile Daniel ; Dugic, Ana.
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20290.  , 2022
Link: https://opus4.kobv.de/op..
 
?
4

Fructose-induced severe hypertriglyceridemia and diabetes m..:

Dugic, Ana ; Kryk, Michael ; Mellenthin, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630754/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Ana Dugic ; Cristina Verdejo Gil ; Claudia Mellenthin...
https://www.mdpi.com/2227-9059/10/7/1511.  , 2022
Link: https://doi.org/10.3390/..
 
?
6

The Clinical Utility of Soluble Serum Biomarkers in Autoimm..:

Ana Dugic ; Cristina Verdejo Gil ; Claudia Mellenthin...
Immunology and Immunotherapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
7

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Claudia Mellenthin ; Vasile Daniel Balaban ; Ana Dugic.
Methods and Technologies Development.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

Risk Factors for Pancreatic Cancer in Patients with New-Ons..:

Claudia Mellenthin ; Vasile Daniel Balaban ; Ana Dugic.
https://www.mdpi.com/2072-6694/14/19/4684.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

Fructose-induced severe hypertriglyceridemia and diabetes m..:

Ana Dugic ; Michael Kryk ; Claudia Mellenthin...
https://edm.bioscientifica.com/view/journals/edm/2021/1/EDM21-0110.xml.  , 2021
Link: https://doi.org/10.1530/..
 
?
10

Therapeutic targeting of STAT3 pathways in pancreatic adeno..:

Sarah Peisl ; Claudia Mellenthin ; Lucie Vignot...
https://doi.org/10.1371/journal.pone.0252397.  , 2021
Link: https://doi.org/10.1371/..
 
?
11

Bias assessment of the clinical studies:

Sarah Peisl (10987605) ; Claudia Mellenthin (10987608) ; Lucie Vignot (10987611)...
https://figshare.com/articles/dataset/Bias_assessment_of_the_clinical_studies_/14800731.  , 2021
Link: https://doi.org/10.1371/..
 
?
12

Summary of findings by drug:

Sarah Peisl (10987605) ; Claudia Mellenthin (10987608) ; Lucie Vignot (10987611)...
https://figshare.com/articles/dataset/Summary_of_findings_by_drug_/14800740.  , 2021
Link: https://doi.org/10.1371/..
 
?
13

Bias assessment of preclinical studies:

Sarah Peisl (10987605) ; Claudia Mellenthin (10987608) ; Lucie Vignot (10987611)...
https://figshare.com/articles/dataset/Bias_assessment_of_preclinical_studies_/14800728.  , 2021
Link: https://doi.org/10.1371/..
 
?
14

Characteristics of included clinical studies:

Sarah Peisl (10987605) ; Claudia Mellenthin (10987608) ; Lucie Vignot (10987611)...
https://figshare.com/articles/dataset/Characteristics_of_included_clinical_studies_/14800737.  , 2021
Link: https://doi.org/10.1371/..
 
?
15

PRISMA flow chart of included studies:

Sarah Peisl (10987605) ; Claudia Mellenthin (10987608) ; Lucie Vignot (10987611)...
https://figshare.com/articles/figure/PRISMA_flow_chart_of_included_studies_/14800725.  , 2021
Link: https://doi.org/10.1371/..
 
1-15